ChemoCentryx Inc

NASDAQ:CCXI   3:59:53 PM EDT
33.72
-1.25 (-3.59%)
Products

ChemoCentryx Inc Announces FDA Approval Of Tavneos (AVACOPAN)

Published: 10/08/2021 11:12 GMT
ChemoCentryx Inc (CCXI) - Chemocentryx Announces FDA Approval of Tavneos™ (avacopan) in Anca-associated Vasculitis.
Chemocentryx Inc - Regulatory Decision for Tavneos in Europe Following European Medicines Agency (ema) Review is Expected by End of 2021.